SHORT-BOWEL SYNDROME

This adverse event was reported 651 times

These drugs are most commonly taken by patients reporting SHORT-BOWEL SYNDROME:

# Drug Count
0 ADALIMUMAB 124
1 ERGOCALCIFEROL 61
2 TEDUGLUTIDE 60
3 INFLIXIMAB 58
4 VEDOLIZUMAB 56
5 AZATHIOPRINE 43
6 METHOTREXATE SODIUM 31
7 PANTOPRAZOLE 31
8 PREDNISONE 31
9 OCTREOTIDE ACETATE 30
See all common drugs associated with SHORT-BOWEL SYNDROME

SHORT-BOWEL SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEDUGLUTIDE 60 0.0045
1 I. V. FAT EMULSION 3 0.0041
2 HYDROCORTISONE VALERATE 2 0.0032
3 INFLIXIMAB-DYYB 10 0.0029
4 NALOXONE HCL 2 0.0023
5 ERGOCALCIFEROL 61 0.0021
6 CLONIDINE HYDROCHLORIDE 10 0.0017
7 DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 23 0.0017
8 IMIPENEM AND CILASTATIN SODIUM 3 0.0014
9 CHOLESTYRAMINE 17 0.0014
See all drugs enriched for association with SHORT-BOWEL SYNDROME

SHORT-BOWEL SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Oxaborole Antifungal [EPC] 1 0.0143
1 GLP-2 Analog [EPC] 60 0.0045
2 Vitamin B6 Analog [EPC] 1 0.0028
3 Provitamin D2 Compound [EPC] 61 0.0021
4 Bile Acid Sequestrant [EPC] 17 0.0014
5 Lipid Emulsion [EPC] 3 0.0011
6 Gamma Secretase Inhibitor [EPC] 1 0.0011
7 Enzyme Stabilizer [EPC] 1 0.0009
8 mu-Opioid Receptor Agonist [EPC] 2 0.0007
9 Integrin Receptor Antagonist [EPC] 58 0.0007
See all drug classes enriched for association with SHORT-BOWEL SYNDROME